Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-25-097272

SVP, CFO acquired 3 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Daphne SVP, CFO 2025-07-17 Option exercise +3 3 D
Derivatives
Taylor Daphne SVP, CFO 2025-07-17 Option exercise · Restricted Stock Unit −3 8 D
Loading xslF345X05/ownership.xml…